These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 19781875)

  • 1. Dydrogesterone--a unique progestogen.
    Schindler AE
    Maturitas; 2009 Dec; 65 Suppl 1():S1. PubMed ID: 19781875
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful prevention of preeclampsia in a high-risk pregnancy using progestogen dydrogesterone: a clinical case.
    Tskhay VB; Kovtun NM; Schindler AE
    Horm Mol Biol Clin Investig; 2016 Sep; 27(3):85-8. PubMed ID: 27383893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review on role of progestogen (dydrogesterone) in the prevention of gestational hypertension.
    Mohamad Razi ZR; Schindler AE
    Horm Mol Biol Clin Investig; 2016 Aug; 27(2):73-6. PubMed ID: 27101553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dydrogesterone and the immunology of pregnancy.
    Raghupathy R; Szekeres-Bartho J
    Horm Mol Biol Clin Investig; 2016 Aug; 27(2):63-71. PubMed ID: 26812877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dydrogesterone support in threatened miscarriage.
    El-Zibdeh MY; Yousef LT
    Maturitas; 2009 Dec; 65 Suppl 1():S43-6. PubMed ID: 20007011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dydrogesterone use in early pregnancy.
    Mirza FG; Patki A; Pexman-Fieth C
    Gynecol Endocrinol; 2016; 32(2):97-106. PubMed ID: 26800266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot study to determine whether progestogen supplementation using dydrogesterone during the first trimester will reduce the incidence of gestational hypertension in primigravidae.
    Zainul Rashid MR; Lim JF; Nawawi NH; Luqman M; Zolkeplai MF; Rangkuty HS; Mohamad Nor NA; Tamil A; Shah SA; Tham SW; Schindler AE
    Gynecol Endocrinol; 2014 Mar; 30(3):217-20. PubMed ID: 24552449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The place of dydrogesterone in the treatment of endometriosis and adenomyosis.
    Schweppe KW
    Maturitas; 2009 Dec; 65 Suppl 1():S23-7. PubMed ID: 19945806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dydrogesterone in threatened miscarriage: a Malaysian experience.
    Pandian RU
    Maturitas; 2009 Dec; 65 Suppl 1():S47-50. PubMed ID: 20005647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of dydrogesterone in hormone replacement therapy.
    Mueck AO; Seeger H; Bühling KJ
    Maturitas; 2009 Dec; 65 Suppl 1():S51-60. PubMed ID: 19836909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dydrogesterone and other progestins in benign breast disease: an overview.
    Schindler AE
    Arch Gynecol Obstet; 2011 Feb; 283(2):369-71. PubMed ID: 20383772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spontaneous conception following GnRHa and progestogen therapy in adenomyosis.
    Dasrilsyah RA; Shan LP; Kwang NB; Shafiee MN; Omar MH
    Horm Mol Biol Clin Investig; 2016 Aug; 27(2):77-9. PubMed ID: 26812802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dydrogesterone support following assisted reproductive technique (ART) reduces the risk of pre-eclampsia.
    Ali AB; Ahmad MF; Kwang NB; Shan LP; Shafie NM; Omar MH
    Horm Mol Biol Clin Investig; 2016 Sep; 27(3):93-6. PubMed ID: 26910749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Present and future aspects of dydrogesterone in prevention or treatment of pregnancy disorders: an outlook.
    Schindler AE
    Horm Mol Biol Clin Investig; 2016 Aug; 27(2):49-53. PubMed ID: 27662647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progestational effects of dydrogesterone in vitro, in vivo and on the human endometrium.
    Schindler AE
    Maturitas; 2009 Dec; 65 Suppl 1():S3-11. PubMed ID: 19969432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical observations on luteal phase inadequacy.
    Taubert HD; Jürgensen O; Becker H
    Bull Schweiz Akad Med Wiss; 1970 Oct; 25(4-6):586-94. PubMed ID: 4101703
    [No Abstract]   [Full Text] [Related]  

  • 17. Dydrogesterone and pre-term birth.
    Hudic I; Schindler AE; Szekeres-Bartho J; Stray-Pedersen B
    Horm Mol Biol Clin Investig; 2016 Sep; 27(3):81-3. PubMed ID: 26812800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective post-laparoscopic treatment of endometriosis with dydrogesterone.
    Trivedi P; Selvaraj K; Mahapatra PD; Srivastava S; Malik S
    Gynecol Endocrinol; 2007 Oct; 23 Suppl 1():73-6. PubMed ID: 17943543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of dydrogesterone on the vascular system.
    Seeger H; Mueck AO
    Gynecol Endocrinol; 2007 Oct; 23 Suppl 1():2-8. PubMed ID: 17943533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment options for threatened miscarriage.
    Qureshi NS
    Maturitas; 2009 Dec; 65 Suppl 1():S35-41. PubMed ID: 19945236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.